A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frédéric Pouliot, Stephan Probst, Lawrence Saperstein, Mark A. Preston, Ajjai S. Alva, Akash Patnaik, Jeremy C. Durack, Nancy Stambler, Tess Lin, Jessica Jensen, Vivien Wong, Barry A. Siegel, Michael J. Morris

Open source

DOI: 10.1097/ju.0000000000001698
Published: 2021-07
Container: Journal of Urology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/ju.0000000000001698,
  title = {A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with
                    <sup>18</sup>
                    F-DCFPyL in Prostate Cancer Patients (OSPREY)},
  author = {Kenneth J. Pienta and Michael A. Gorin and Steven P. Rowe and Peter R. Carroll and Frédéric Pouliot and Stephan Probst and Lawrence Saperstein and Mark A. Preston and Ajjai S. Alva and Akash Patnaik and Jeremy C. Durack and Nancy Stambler and Tess Lin and Jessica Jensen and Vivien Wong and Barry A. Siegel and Michael J. Morris},
  year = {2021},
  journal = {Journal of Urology},
  doi = {10.1097/ju.0000000000001698},
  url = {https://doi.org/10.1097/ju.0000000000001698}
}

RIS

TY  - JOUR
TI  - A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with
                    <sup>18</sup>
                    F-DCFPyL in Prostate Cancer Patients (OSPREY)
AU  - Kenneth J. Pienta
AU  - Michael A. Gorin
AU  - Steven P. Rowe
AU  - Peter R. Carroll
AU  - Frédéric Pouliot
AU  - Stephan Probst
AU  - Lawrence Saperstein
AU  - Mark A. Preston
AU  - Ajjai S. Alva
AU  - Akash Patnaik
AU  - Jeremy C. Durack
AU  - Nancy Stambler
AU  - Tess Lin
AU  - Jessica Jensen
AU  - Vivien Wong
AU  - Barry A. Siegel
AU  - Michael J. Morris
PY  - 2021
JO  - Journal of Urology
DO  - 10.1097/ju.0000000000001698
UR  - https://doi.org/10.1097/ju.0000000000001698
ER  -

APA

Pienta, K. J., Gorin, M. A., Rowe, S. P., Carroll, P. R., Pouliot, F., Probst, S., Saperstein, L., Preston, M. A., Alva, A. S., Patnaik, A., Durack, J. C., Stambler, N., Lin, T., Jensen, J., Wong, V., Siegel, B. A., & Morris, M. J. (2021). A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY). Journal of Urology. https://doi.org/10.1097/ju.0000000000001698

Source records

crossref · retrieved 2026-09-27T06:27:05.585Z